
Home
Chapter Home
Jobs
Conferences
Fellowships
Books
Advertisement
Liver and intrahepatic bile ducts - tumor
Other malignancies
Combined hepatocellular carcinoma - cholangiocarcinoma
Reviewers: Nat Pernick, M.D. (see Reviewers page)
Revised: 5 January 2013, last major update August 2012
Copyright: (c) 2004-2013, PathologyOutlines.com, Inc.
General
=========================================================================
● Tumor with unequivocal, intimately mixed elements of both hepatocellular carcinoma (HCC) and cholangiocarcinoma (ChC) (WHO)
● Must distinguish from separate HCC and ChC arising in same liver, which are either separated or intermixed (“collision tumor”)
● Includes "transitional" types with primarily features intermediate between hepatocellular carcinoma and cholangiocarcinoma (Am J Surg Pathol 2002;26:989)
● < 5% of primary hepatic carcinomas
● Aggressive, with 5 year survival of 18% overall and 24% after resection (worse than pure hepatocellular carcinoma or cholangiocarcinoma, Clin Med Pathol 2008;1:43)
● Poor prognosis and high rate of tumor recurrence after liver transplantation (Liver Transpl 2011;17:934)
● Laboratory: serum alpha-fetoprotein usually normal, usually negative for Hepatitis B and C serum markers
Case reports
=========================================================================
● 53 year old man with Hepatitis B and weight loss (Cases J 2009;2:6789)
Gross description
=========================================================================
● 3-16 cm, solitary or multiple tumor nodules
● Pale-tan to bile stained, variably fibrotic and hemorrhagic or necrotic
Gross images
=========================================================================
Poorly circumscribed mass with extensive necrosis
Micro description
=========================================================================
● Intimate admixture of tumor cells with features of unequivocal hepatocellular carcinoma and cholangiocarcinoma (cuboidal / columnar cells with amphophilic cytoplasm, inconspicuous nucleoli, gland formation and mucin)
● May have sarcomatoid component or cirrhosis
● Transitional tumors have no distinct hepatocellular or cholangiocarcinoma-like areas; usually no cirrhosis; areas with “antler-like” morphology in 33% (irregular thin branching columns of hepatoid cells separated by broad desmoplastic stromal bands), rarely papillary
Micro images
=========================================================================
Various images
Left: H&E; right: CK7
Positive stains
=========================================================================
● Albumin mRNA by ISH (96%); cytokeratin, EMA and mucicarmine in glandular areas
Differential diagnosis
=========================================================================
● Hepatocellular carcinoma with pseudoglandular spaces but not true glands
● Undifferentiated carcinoma: features suggestive but not diagnostic of both tumor types, may represent metastatic diseases
End of Liver and intrahepatic bile ducts - tumor > Other malignancies > Combined hepatocellular carcinoma - cholangiocarcinoma
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com
with any questions (click here for other
contact information).